The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
Starting a new exercise program is a powerful step toward better health, especially for those living with diabetes. However, ...
Morning Overview on MSN
Statins helped nearly everyone with type 2 diabetes live longer, even low-risk patients
People with type 2 diabetes who started taking statins lived longer than those who did not, even when their predicted risk of ...
A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...
After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results